Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

David Udis

Diagnostic Radiology Philadelphia, PA Medical Doctor

NPI 1861486409 CMS profile 900199

8835 Germantown Ave, Philadelphia, PA 19118

Open in the dashboard

General payments

$198,205

210 records reported · program years 2019–2025

Research payments

$63,202

Paid to them · 15 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, David Udis of Philadelphia, PA is reported in the CMS Open Payments database as having received $198,205 across 210 general payments and $63,202 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Diagnostic Radiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

11 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $238 4
2025 Research $6,477 4
2024 General $14 1
2024 Research $7,750 2
2023 Research $29,225 2
2022 Research $17,890 5
2021 General $113,852 107
2021 Research $1,630 1
2020 General $80,200 83
2020 Research $230 1
2019 General $3,900 15

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • David Udis
  • Diagnostic Radiology median
  • Middle half of Diagnostic Radiology
  • National median

In program year 2025, general payments to David Udis were reported at $238. Among 8,325 Diagnostic Radiology profiles paid that year, the median was $112 and the middle half received between $32 and $349.

Show as a table
Year David Udis Diagnostic Radiology median Middle half National median
2019 $3,900 $108 $29–$318 $163
2020 $80,200 $65 $21–$252 $114
2021 $113,852 $92 $24–$292 $132
2022 $0 $104 $29–$294 $149
2023 $0 $110 $29–$337 $160
2024 $14 $113 $30–$356 $164
2025 $238 $112 $32–$349 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Merck Sharp & Dohme Corporation $197,935 204 payments
  2. HeartFlow, Inc. $238 4 payments
  3. Medtronic, Inc. $17 1 payment
  4. Philips Electronics North America Corporation $14 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $197,935 204 payments
  2. Food and Beverage $270 6 payments
Products named General payments · program years 2019–2025
  1. LENVIMA $142,700 106 payments
  2. KEYTRUDA $55,235 98 payments
  3. FFRct $238 4 payments
  4. Chameleon $17 1 payment
  5. (8317) ProxiDiagnost N90 High Performance $14 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. E.R. Squibb & Sons, L.L.C. $42,235 7 payments
  2. Eli Lilly and Company $20,967 8 payments

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

12

Median for Diagnostic Radiology: 24

Drug cost

$6,223

Median for Diagnostic Radiology: $190

Branded share of claims

100%

Median for Diagnostic Radiology: 0%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Jardiance Empagliflozin Brand 12 $6,223

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 1,198 Part D prescribers listed as Diagnostic Radiology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 203 billing codes

Paid by Medicare

$168,884

Medicare's payments for the services billed

Medicare patients

3,594

Average age 75

Services billed

6,375

2,409 women, 1,185 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 55%
Diabetes 35%
Ischemic heart disease 33%
Chronic kidney disease 30%
Depression 30%
Heart failure 26%
COPD 25%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

225 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Diagnostic Radiology in Pennsylvania

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record